Napo Pharmaceuticals
Crofelemer
A proprietary gastro-intestinal compound in clinical development for four distinct product indications
 |
 |
 |
|
||
 |
|
 |
|
||
news
December 30, 2010
Napo CEO Lisa Conte Featured in Forbes Magazine
November 4, 2010
Crofelemer Demonstrates Highly Statistically Significant Results in
the Treatment of Chronic Diarrhea in People Living with
HIV/AIDS
October 26, 2010
Letter to Shareholders
April 20, 2010
Napo Enters Finder's Agreement for Development of Crofelemer in China
If you would like to receive e-mail alerts when we send out press releases, please
send an e-mail to news@napopharma.com
with the subject 'subscribe'.
December 30, 2010
Napo CEO Lisa Conte Featured in Forbes Magazine
November 4, 2010
Crofelemer Demonstrates Highly Statistically Significant Results in
the Treatment of Chronic Diarrhea in People Living with
HIV/AIDS
October 26, 2010
Letter to Shareholders
April 20, 2010
Napo Enters Finder's Agreement for Development of Crofelemer in China
